CA2329676A1 - Salmonella vaccine - Google Patents

Salmonella vaccine Download PDF

Info

Publication number
CA2329676A1
CA2329676A1 CA002329676A CA2329676A CA2329676A1 CA 2329676 A1 CA2329676 A1 CA 2329676A1 CA 002329676 A CA002329676 A CA 002329676A CA 2329676 A CA2329676 A CA 2329676A CA 2329676 A1 CA2329676 A1 CA 2329676A1
Authority
CA
Canada
Prior art keywords
bacterium
flagellin
vaccine
bacteria
salmonella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002329676A
Other languages
English (en)
French (fr)
Inventor
Petrus Johannes Maria Nuijten
Maarten Hendrik Witvliet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of CA2329676A1 publication Critical patent/CA2329676A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002329676A 1999-12-28 2000-12-27 Salmonella vaccine Abandoned CA2329676A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99204564.1 1999-12-28
EP99204564 1999-12-28

Publications (1)

Publication Number Publication Date
CA2329676A1 true CA2329676A1 (en) 2001-06-28

Family

ID=8241112

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002329676A Abandoned CA2329676A1 (en) 1999-12-28 2000-12-27 Salmonella vaccine

Country Status (15)

Country Link
US (2) US20010021386A1 (cg-RX-API-DMAC7.html)
EP (1) EP1112747B1 (cg-RX-API-DMAC7.html)
JP (1) JP5745731B2 (cg-RX-API-DMAC7.html)
AT (1) ATE269104T1 (cg-RX-API-DMAC7.html)
AU (1) AU783508B2 (cg-RX-API-DMAC7.html)
BR (1) BR0006291B1 (cg-RX-API-DMAC7.html)
CA (1) CA2329676A1 (cg-RX-API-DMAC7.html)
DE (1) DE60011560T2 (cg-RX-API-DMAC7.html)
DK (1) DK1112747T3 (cg-RX-API-DMAC7.html)
ES (1) ES2222152T3 (cg-RX-API-DMAC7.html)
HU (1) HU226192B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA00012796A (cg-RX-API-DMAC7.html)
PL (1) PL206377B1 (cg-RX-API-DMAC7.html)
PT (1) PT1112747E (cg-RX-API-DMAC7.html)
TR (1) TR200401569T4 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4751570B2 (ja) * 2002-09-11 2011-08-17 東レ・ダウコーニング株式会社 オルガノポリシロキサン変性多糖類およびその製造方法
PL2066339T3 (pl) 2006-09-18 2015-02-27 Univ Arkansas Kompozycje i sposoby zwiększania odpowiedzi immunologicznych
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
CA2704457A1 (en) * 2007-10-30 2009-05-07 Walter Bottje Compositions and methods of enhancing immune responses to flagellated bacterium
AU2008318357B2 (en) 2007-11-01 2015-01-22 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria
WO2009062112A2 (en) 2007-11-09 2009-05-14 The Salk Institute For Biological Studies Use of tam receptor inhibitors as antimicrobials
DK2525817T3 (en) 2010-01-21 2017-10-02 Univ Arkansas Vaccine vectors and methods for enhancing immune responses
NZ718006A (en) 2010-06-09 2017-06-30 Univ Arkansas Vaccine and methods to reduce campylobacter infection
KR101449417B1 (ko) 2012-06-20 2014-10-27 한국외국어대학교 연구산학협력단 살모넬라 엔테리카의 박테리오파아지 및 그 용도
RU2683027C2 (ru) 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
CA2900644C (en) 2013-02-14 2023-03-14 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
WO2014164607A1 (en) 2013-03-11 2014-10-09 The Brigham And Women's Hospital, Inc. Vibro-based delivery system and immune suppression
AU2014239557B2 (en) 2013-03-15 2019-01-03 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
TWI843057B (zh) 2016-05-03 2024-05-21 阿肯色州大學董事會 包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法
CN111374094B (zh) * 2020-03-02 2022-04-19 扬州大学 驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法
CN118773056B (zh) * 2024-07-10 2025-07-08 山东省滨州畜牧兽医研究院 一种马流产沙门氏菌灭活疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1109179A (en) * 1964-09-30 1968-04-10 Nat Res Dev Improvements relating to typhoid and paratyphoid vaccines
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.
DE68922394T2 (de) * 1988-05-05 1995-10-05 Praxis Biolog Inc Rekombinante vakzine von flagellin.
US6130082A (en) * 1988-05-05 2000-10-10 American Cyanamid Company Recombinant flagellin vaccines
JP3436756B2 (ja) * 1988-12-19 2003-08-18 アメリカン・サイアナミド・カンパニー 髄膜炎菌のクラスｉの外膜タンパク質のワクチン
DE69528450T2 (de) * 1994-02-18 2003-01-23 Solidose, L.L.C. Impfung von tieren mit getrockneten pelletierten biologischen materialien
GB9621091D0 (en) * 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
DK1112747T3 (da) 2004-10-25
MXPA00012796A (es) 2002-05-23
PT1112747E (pt) 2004-10-29
EP1112747B1 (en) 2004-06-16
DE60011560D1 (de) 2004-07-22
BR0006291B1 (pt) 2014-02-18
DE60011560T2 (de) 2005-08-18
PL206377B1 (pl) 2010-08-31
US20080069843A1 (en) 2008-03-20
AU783508B2 (en) 2005-11-03
ES2222152T3 (es) 2005-02-01
JP2001186874A (ja) 2001-07-10
BR0006291A (pt) 2001-11-27
HUP0005010A2 (en) 2002-06-29
EP1112747A1 (en) 2001-07-04
PL344851A1 (en) 2001-07-02
JP5745731B2 (ja) 2015-07-08
ATE269104T1 (de) 2004-07-15
TR200401569T4 (tr) 2004-07-21
HU226192B1 (en) 2008-06-30
US20010021386A1 (en) 2001-09-13
AU7245300A (en) 2001-07-05
HU0005010D0 (cg-RX-API-DMAC7.html) 2001-02-28
HUP0005010A3 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
US20080069843A1 (en) Salmonella vaccine
JP2002521345A (ja) 鳥類病原体を制御するため生きた弱毒化サルモネラワクチン
US7045122B2 (en) Salmonella vaccine
US20080254062A1 (en) Use of an avirulent bordetella mutant as a live vaccine vector
HUP0201117A2 (en) Attenuated microorganisms for the treatment of infection
US11298416B2 (en) Modified Brucella vaccine strain for the treatment of brucellosis
JP6329544B2 (ja) 新規生弱毒化赤痢菌属（Ｓｈｉｇｅｌｌａ）ワクチン
JP2009531029A (ja) 弱毒化サルモネラ生ワクチン
US8163297B2 (en) Live attenuated aldolase-negative bacterial vaccine
AU3935300A (en) Live attenuated bacteria for use in a vaccine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued